Wednesday, December 13, 2017
 
 
Company News: Page (1) of 1 - 09/10/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Lilly Builds Upon Body of Clinical Evidence for CYRAMZA® (ramucirumab) with Phase 3 RANGE Data Demonstrating Superior Progression-Free Survival in Advanced or Metastatic Urothelial Cancer
Randomized, placebo-controlled study confirms ramucirumab, in combination with docetaxel, significantly extended progression-free survival (PFS) in patients with platinum-refractory advanced urothelia...
(September 10, 2017)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:USA,Medicine,Disease,Surgery,healthcare,medical technologists,Pregnancy,Cancer,Surgery,Medication,Womens Health,Pregnancy,Science,Medical,Biology,Cancer,Other,Women,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • ApolloMed And Network Medical Management Announce Completion Of Merger And Listing On The Nasdaq Capital Market
  • Global Protein Expression Market 2016-2023: Market is Expected to Grow from $1.4 Billion to $3.0 Billion
  • Dental Unit Market To Witness Enhanced Demand From Hospitals And Clinics, Dental Laboratories And Various Healthcare Sectors Till 2022 | Million Insights
  • Global $14.3 Billion Infusion Pump System Accessories and Software Market, 2017-2024
  • Silmäasema Oyj: Silmäasema supports the proposal of using client vouchers to pay for treating cataract and other eye diseases

    Cancer
  • Targovax to present at DNB healthcare conference
  • Drug of Abuse Testing Services Market Size Worth $2.9 Billion By 2025: Grand View Research, Inc.
  • Award-winning Independent Family Adventure Movie "Thrill Ride" Released on DVD and Streaming Tuesday, December 12th
  • TruTag® On-Dose Identity Solution Launched by The Daily Wellness Company for Its Clinically-Validated Natural Health Products
  • Cloaked Therapeutics Development, LLC
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines